tbuckley/cabot-search huggingface dataset:
Cerebral Autoregulation-Targeted Mean Arterial Pressure—Reply
Authors: Charles H. Brown, Charles W. Hogue
Journal: JAMA Surgery (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
Transplantation Of Peripheral Blood Progenitor Cells (PBPC) As Compared To Bone Marrow (BM) From Unrelated Related Donors For Hematologic Cancers Using Fludarabine-Alkylating Agent Based Reduced Intensity Conditioning Regimens
Authors: Mary Eapen, Brent R. Logan, Mary M. Horowitz, Xiaobo Zhong, Miguel Angel Perales, Stephanie J. Lee, Vanderson Rocha, Robert J. Soiffer, Daniel J. Weisdorf, Richard E Champlin
Journal: Blood (2013)
Laulimalide and taxotere inhibit human endothelial cell migration by different patterns of inhibition of phosphorylation of focal adhesion kinase (FAK) and paxillin
Authors: Haiyan Lu, Edward L. Schwartz
Journal: Cancer Research (2004)

2583  Microtubule-binding agents have been shown to be highly potent inhibitors of angiogenesis, and in this study we examined the mechanism by which they inhibited human umbilical vein endothelial cell migration (HUVEC) in vitro. The agents studied were taxotere (docetaxel) and laulimalide, a microtubule-stabilizing agent originally isolated from marine sponges and found to bind to the tubulin polymer at a site distinct from the taxoid site. Studies have also shown laulimalide to be active against tumor cells that were resistant to the taxanes and other drugs due either to overexpression of P-glycoprotein or due to mutations in the β-tubulin gene. In the present study, we found that taxotere and laulimalide inhibited HUVEC migration with IC50s of 0.08 and 0.7 nM, respectively, and also inhibited HUVEC tubule formation. Inhibition of HUVEC proliferation required concentrations 6-11 fold higher. VEGF-induced endothelial cell migration is mediated by the tyrosine phosphorylation and activation of its receptor tyrosine kinases, followed by downstream signaling events which include the formation of focal adhesions and the phosphorylation of proteins involved in cell migration such as focal adhesion kinase (FAK) and paxiliin, a 68 kDa focal adhesion-associated component. Using phosphorylation site-specific antibodies, we found that VEGF rapidly induced the phosphorylation of Tyr951 of VEGFR-2 (KDR), multiple tyrosine residues on FAK, and the Tyr31 residue of paxillin. Neither laulimalide nor taxotere affected the extent of VEGF-induced VEGFR-2 phosphorylation in HUVEC. Laulimalide at 0.1 nM did, however, substantially block the phosphorylation of the Tyr397 residue of FAK, the autophosphorylation site, and had a lesser effect on the phosphorylation of the Tyr407 residue. Taxotere at 0.1 nM, in contrast, had the opposite effect, showing a greater inhibition of the Tyr407 residue when compared to its effect on Tyr397. Both agents were weaker inhibitors of the phosphorylation of FAK at the src kinase sites Tyr576 and Tyr577 and at the p130Cas-binding site Tyr861. Both laulimalide and taxotere at 0.1 nM inhibited the tyrosine phosphorylation of paxillin. In conclusion, signal transduction pathways that regulate endothelial cell migration are inhibited by laulimalide and taxotere at the level of the focal adhesion, and this might contribute to their anti-angiogenic actions. Further, the different patterns of inhibition observed between the two agents could be due to their differing binding sites on the tubulin polymer.
Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge Trial –
Authors: Jan Moritz Middeke, Regina Herbst, Stefani Parmentier, Gesine Bug, Mathias Hänel, Gernot Stuhler, Kerstin Schäfer-Eckart, Wolf Rösler, Stefan A. Klein, Wolfgang A Bethge, Ulrich Bitz, Nael Alakel, Markus Schaich, Anke Morgner, Stefan Pursche, Michael Kramer, Uwe Platzbecker, Christoph Röllig, Christian Thiede, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig
Journal: Blood (2013)
European Post-Approval Safety Study (PASS) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including SPM, in a Large Cohort of Patients Treated with Lenalidomide, Thalidomide, and Bortezomib
Authors: Barbara Gamberi, Miguel Hernandez, Christian Berthou, Eleni Tholouli, Elena Zamagni, Roman Hájek, Monique Minnema, Meletios A Dimopoulos, Jo Caers, Niels Frost Andersen, Bjorn Andreasson, Anders Waage, Gerard Crotty, Elisabeth Kueenburg, Barbara Rosettani, Antonia Di Micco, Pamela Bacon, Igor Blau
Journal: Blood (2016)
Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis
Authors: Christian Hampp, Richard S. Swain, Casie Horgan, Elizabeth Dee, Yandong Qiang, Sarah K. Dutcher, Andrew Petrone, Rong Chen Tilney, Judith C. Maro, Catherine A. Panozzo
Journal: Diabetes Care (2019)

To estimate real-world off-label use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 1 diabetes, estimate rates of diabetic ketoacidosis (DKA), and compare them with DKA rates observed in sotagliflozin clinical trials.We identified initiators of SGLT2 inhibitors in the Sentinel System from March 2013 to June 2018, determined the prevalence of type 1 diabetes using a narrow and a broad definition, and measured rates of DKA using administrative claims data. Standardized incidence ratios (SIRs) were calculated using age- and sex-specific follow-up time in Sentinel and age- and sex-specific DKA rates from sotagliflozin trials 309, 310, and 312.Among 475,527 initiators of SGLT2 inhibitors, 0.50% and 0.92% met narrow and broad criteria for type 1 diabetes, respectively. Rates of DKA in the narrow and broad groups were 7.3/100 person-years and 4.5/100 person-years, respectively. Among patients who met narrow criteria for type 1 diabetes, rates of DKA were highest for patients aged 25-44 years, especially females aged 25-44 years (19.7/100 person-years). More DKA events were observed during off-label use of SGLT2 inhibitors in Sentinel than would be expected based on sotagliflozin clinical trials (SIR = 1.83; 95% CI 1.45-2.28).Real-world off-label use of SGLT2 inhibitors among patients with type 1 diabetes accounted for a small proportion of overall SGLT2 inhibitor use. However, the risk for DKA during off-label use was notable, especially among young, female patients. Although real-word rates of DKA exceeded the expectation based on clinical trials, results should be interpreted with caution due to differences in study methods, patient samples, and study drugs.
Dual Inhibition of Histone Deacetylases and Phosphoinositide 3-Kinase Enhances Therapeutic Activity Against B Cell Lymphoma
Authors: Patrizia Mondello, Enrico Derenzini, Zahra Asgari, John Philip, Elliot J Brea, Venkatraman E Seshan, Ronald Hendrickson, Elisa de Stanchina, David A Scheinberg, Anas Younes
Journal: Blood (2016)
Platelet Desialylation: A Novel Mechanism of Fc-Independent Platelet Clearance and a Potential Diagnostic Biomarker and Therapeutic Target in immune Thrombocytopenia
Authors: June Li, Dianne Evertdina van der Wal, Guangheng Zhu, Miao Xu, Issaka Yougbare, Li Ma, Brian Vadasz, Renata Grozovsky, Min Ruan, Lingyan Zhu, Qingshu Zeng, Lili Tao, Zhi-min Zhai, Jun Peng, Ming Hou, Valery Leytin, John J. Freedman, Karin M Hoffmeister, Heyu Ni
Journal: Blood (2014)
Monozygotic Twins Display Different Minor Histocompatibility Antigens.
Authors: Miroslaw Markiewicz, Urszula Siekiera, Monika Dzierzak Mietla, Agnieszka Karolczyk, Tomasz Kruzel, Grzegorz Helbig, Slawomira Kyrcz-Krzemien
Journal: Blood (2009)
Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)
Authors: Sylvie Castaigne, Cécile Pautas, Christine Terre, Emmanuel Raffoux, Dominique Bordessoule, Jean-Noel Bastie, Ollivier Legrand, Xavier Thomas, Pascal Turlure, Oumedaly Reman, Thierry De Revel, Lauris Gastaud, Claude Gardin, Laurent Sutton, Jean Pierre Marolleau, Stephane De Botton, Olivier Hermine, Isabelle Plantier, Maud Janvier, Brigitte Dupriez, Marc Simon, Noemie De Gunzburg, Stephanie Foucault-Haiat, Nathalie Contentin, Celine Berthon, Pierre Fenaux, Estelle Henry, Philippe Rousselot, Claude Preudhomme, Sylvie Chevret, Hervé Dombret
Journal: Blood (2011)
Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis
Authors: Jay Ramchand, Sheila K Patel, Leighton G Kearney, George Matalanis, Omar Farouque, Piyush M Srivastava, Louise M Burrell
Journal: JACC. Cardiovascular imaging (2019)
Acquired Molecular Defects in Spliceosome Machinery: Novel Pathogenetic Pathways in Myeloid Leukemogenesis
Authors: Hideki Makishima, Hirotoshi Sakaguchi, Valeria Visconte, Andres Jerez, Anna M Jankowska, Kathryn M Guinta, Hideki Muramatsu, Mikkael A Sekeres, Seiji Kojima, Ramon V. Tiu, Jaroslaw P. Maciejewski
Journal: Blood (2011)
A Pilot Study of Peripheral Blood Hematopoietic Stem Cells Mobilization with the Combination of Bortezomib and G-CSF in Multiple Myeloma and Non-Hodgkin's Lymphoma Patients.
Authors: Divaya Bhutani, Vidya sri Kondadasula, Joseph P. Uberti, Voravit Ratanatharathorn, Lawrence G. Lum, Abhinav Deol, Lois Ayash, Muneer H. Abidi
Journal: Blood (2015)
Association Between Multiple Mismatches at the HLA-DPB1 and DRB3/4/5 Genes and Adverse Outcomes in HLA-a, -B, -C, -DRB1 and -DQB1 Identical Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society for Histocompatibility and Immunogenetics (SFHI)
Authors: Stephanie Ducreux, Valérie Dubois, Pascal Loiseau, Ibrahim Yakoub-Agha, Myriam Labalette, Mauricette Michallet, Marie t Rubio, Anne Kennel, Edouard Forcade, Xavier Lafarge, Jean-Yves Cahn, Dominique Masson, Etienne Daguindau, Anne Dormoy, Natacha Maillard, Isabelle Jollet, Patrice Chevallier, Anne Cesbron, Jacques-Olivier Bay, Fabienne Quainon, Kahina Amokrane, Gerard Socie, Raphael Porcher, Regis Peffault De Latour
Journal: Blood (2016)
Adding The KIT Inhibitor Dasatinib (DAS) To Standard Induction and Consolidation Therapy For Newly Diagnosed Patients (pts) With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML): Initial Results Of The CALGB 10801 (Alliance) Study
Authors: Guido Marcucci, Susan Geyer, John Zhao, Andrew J Caroll, Donna Bucci, Ravi Vij, William Blum, Timothy Pardee, Meir Wetzler, Wendy Stock, Clara D. Bloomfield, Richard A. Larson, Richard M. Stone
Journal: Blood (2013)
Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)
Authors: Mathilde Hunault-Berger, Thibaut Leguay, Françoise Huguet, Stéphane Leprêtre, Eric Deconinck, Mario Ojeda Uribe, Caroline Bonmati, Pierre Bories, Chantal Himberlin, Patrice Chevallier, Philippe Rousselot, Oumedaly Reman, Marie-Laure Boulland, Severine Lissandre, Pascal Turlure, Didier Bouscary, Laurence Sanhes, Ollivier Legrand, Isabelle Plantier, Frédérique Orsini Piocelle, Véronique Lhéritier, Elodie Boucher, Yann Godfrin, Norbert Ifrah, Hervé Dombret
Journal: Blood (2012)
Thrombin Generation Assay During Orthopaedic Surgery In Hemophilia A With and Without Inhibitors: Results From In Vivo Studies
Authors: Maria Elisa Mancuso, Armando Tripodi, Veena Chantarangkul, Maria Rosaria Fasulo, Marigrazia Clerici, Lidia Padovan, Erica Scalambrino, Flora Peyvandi, Elena Santagostino
Journal: Blood (2013)
Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients.
Authors: Roberto Rodriguez, Joycelynne Palmer, Ryotaro Nakamura, Pablo Miguel Parker, Auayporn P. Nademanee, David S. Snyder, Vinod Pullarkat, Jasmine M. Zain, Ricardo Spielberger, David Senitzer, Stephen J. Forman
Journal: Blood (2006)
Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines
Authors: Sarwar Beg, S.M. Kawish, Sunil K. Panda, Mohammed Tarique, Arshi Malik, Sarah Afaq, Awad Saeed Al-Samghan, Jawed Iqbal, Kainat Alam, Mahfoozur Rahman
Journal: Seminars in Cancer Biology (2019)
Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.
Authors: Xavier Leleu, Lian Xu, Zachary R. Hunter, Sophia Adamia, Evdoxia Hatjiharissi, Anne-Sophie Moreau, Aldo Roccaro, Antonio Sacco, Brian Ciccarelli, Robert J. Manning, Christopher J. Patterson, Irene M. Ghobrial, Steven P. Treon
Journal: Blood (2007)
Evaluation of a Standardized Approach to the Diagnosis of Mild Platelet Function Defects: Recommendation for a Targeted Approach to the Diagnosis of Mild Platelet Function Defects and Identification of a Subset of Children with a "Developmental" Form
Authors: Jessica A Lake, Kenneth D Friedman, Veronica H Flood, Shawn M Jobe, Rowena Punzalan, Joan Cox Gill
Journal: Blood (2015)
Pharmacokinetics and Safety of a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation
Authors: Cesar O. Freytes, Juan J. Toro, Rosa F. Yeh, Edward A. Stadtmauer, Voravit Ratanatharathorn, Gorgun Akpek, Entezam Sahovic, Guido J. Tricot, Paul J. Shaughnessy, Darrell J. White, Tulio E. Rodriguez, Scott R. Solomon, Louie H. Yu, Shiva Patil, Yiping Sun, Elizabeth Armstrong, Agnes Elekes, Kazunobu Kato, Donna E. Reece
Journal: Blood (2011)
Gene Expression Profiling of Extramedullary Disease-Related Toward Identification of a Terminal Disease Pathway in Multiple Myeloma
Authors: Sarah Waheed, Hongwei Wang, Pingping Qu, Christoph Heuck, Aasiya Matin, Yogesh Jethava, Frits van Rhee, Antje Hoering, Bart Barlogie, Faith E Davies, Gareth J Morgan
Journal: Blood (2015)
International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.
Authors: Agnieszka Korfel, Kristoph Jahnke, Brian P. O’Neill, Jean-Yves Blay, Lauren Abrey, Peter Martus, Philip M.P. Poortmans, Tamara N. Shenkier, Tracy T. Batchelor, Edward A. Neuwelt, Jeffrey J. Raizer, Hendrik Pels, Ulrich Herrlinger, Eckhard Thiel
Journal: Blood (2005)
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses.
Authors: Valentina Marchica, Gaetano Donofrio, Rosanna Vescovini, Giulia Tebaldi, Alfonso Rosamilia, Daniela Guasco, Paola Storti, Marina Bolzoni, Federica Costa, Chiara Schifano, Sabrina Bonomini, Fabrizio Accardi, Francesco Piazza, Franco Aversa, Nicola Giuliani
Journal: Blood (2016)
Microrna-106b~25 Cluster Is Involved in Relapsed MLL-Rearranged Pediatric AML
Authors: Lonneke Verboon, Maarten Fornerod, Askar Obulkasim, Edwin Sonneveld, André Baruchel, Jan Trka, Dirk Reinhardt, Rob Pieters, Jacqueline Cloos, Gertjan JL Kaspers, Jan-Henning Klusmann, C. Michel Zwaan, Marry van den Heuvel-Eibrink
Journal: Blood (2014)
Cognitive Impairment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
Authors: Desiree Jones, Elisabeth G Vichaya, Jeffrey S Wefel, Melissa S.Y. Thong, Tito R Mendoza, Loretta A Williams, Charles S Cleeland, Xin Shelley Wang
Journal: Blood (2012)
Development of novel in vitro diagnostics to predict the efficacy of anti-EGFR treatment based on DNA methylation status
Authors: Kota Ouchi, Shin Takahashi, Akira Okita, Yasuhiro Sakamoto, Osamu Muto, Kenji Amagai, Takaho Okada, Hisatugu Ohori, Eiji Shinozaki, Makio Gamou, Chikashi Ishioka
Journal: Annals of Oncology (2019)
Home Azacitidine Administration in High Risk Myelodysplastic Syndromes: Favorable Results of a Pilot Study in 48 Patients
Authors: Sylvestre Guillevic, Thibault Comont, Jonathan Khalifa, Christian Recher, Daniel Adoue, Sylvie Ollier, Pierre Cougoul, Guy Laurent, Odile Beyne-Rauzy
Journal: Blood (2011)
Imatinib as Second-Line Therapy, Ameliorates or Maintains Molecular Responses Obtained with Ponatinib First-Line in Chronic Phase CML Patients
Authors: Franck E. Nicolini, Gaelle Fossard, Valerie Coiteux, Viviane Dubruille, Vincent Alcazer, Mohamad Sobh, Pierre Mouchel, Francois-Xavier Mahon, Gabriel Etienne, Agnes Guerci
Journal: Blood (2016)
Targeting Meningeoma-1 Driven AML through Epigenetic Modulation of the Cell of Origin
Authors: Simone Riedel, Kathrin M Bernt, Jessica Haladyna, Matthew Bezzant, Brett Stevens, Daniel A. Pollyea, Amit U. Sinha, Scott A. Armstrong, Qi Wei, Craig T. Jordan, Tobias Neff
Journal: Blood (2014)
Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer
Authors: Changhao Chen, Yuming Luo, Wang He, Yue Zhao, Yao Kong, Hongwei Liu, Guangzheng Zhong, Yuting Li, Jun Li, Jian Huang, Rufu Chen, Tianxin Lin
Journal: Journal of Clinical Investigation (2019)

Patients with bladder cancer (BCa) with clinical lymph node (LN) metastasis have an extremely poor prognosis. VEGF-C has been demonstrated to play vital roles in LN metastasis in BCa. However, approximately 20% of BCa with LN metastasis exhibits low VEGF-C expression, suggesting a VEGF-C–independent mechanism for LN metastasis of BCa. Herein, we demonstrate that BCa cell–secreted exosome-mediated lymphangiogenesis promoted LN metastasis in BCa in a VEGF-C–independent manner. We identified an exosomal long noncoding RNA (lncRNA), termed lymph node metastasis-associated transcript 2 (LNMAT2), that stimulated human lymphatic endothelial cell (HLEC) tube formation and migration in vitro and enhanced tumor lymphangiogenesis and LN metastasis in vivo. Mechanistically, LNMAT2 was loaded to BCa cell–secreted exosomes by directly interacting with heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1). Subsequently, exosomal LNMAT2 was internalized by HLECs and epigenetically upregulated prospero homeobox 1 (PROX1) expression by recruitment of hnRNPA2B1 and increasing the H3K4 trimethylation level in the PROX1 promoter, ultimately resulting in lymphangiogenesis and lymphatic metastasis. Therefore, our findings highlight a VEGF-C–independent mechanism of exosomal lncRNA-mediated LN metastasis and identify LNMAT2 as a therapeutic target for LN metastasis in BCa.
Ex Vivo Generated Cytotoxic T Cells (CTL) for Adoptive Immunotherapy across MHC Barriers Retain Anti-Leukemic Capacity (GVL) without Eliciting Graft Versus Host Disease (GVHD): Crucial Role of Recipient-Derived Antigen Presenting Cells (APC).
Authors: Arnab Ghosh, Martin Hapke, Florian Laenger, Ralf Baumann, Christian Koenecke, Karl Welte, Martin Sauer
Journal: Blood (2006)
Comprehensive Analysis of Pre-Transplant Pulmonary Function Test Parameters Including FEV1, FVC, DLco, FEF50%/75%, Frc, RV and TLC As Prognostic Factors for Long-Term Outcomes after Allogeneic Transplantation
Authors: Wilson Lam, Uday Deotare, Jeffrey H. Lipton, Theodore Marras, Hans A. Messner, Fotios V. Michelis, Shikha Mittoo, Santhosh Thyagu, Auro Viswabandya, Dennis Dong Hwan Kim
Journal: Blood (2016)
Phase 1 Trial of Flavopiridol and Lenalidomide In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL)
Authors: Kristie A. Blum, Jeffrey A. Jones, Leslie Andritsos, Joseph M. Flynn, Deidre Deam, Nyla A. Heerema, Mitchell Phelps, Amy J Johnson, Michael R. Grever, John C. Byrd
Journal: Blood (2010)
The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Authors: Craig H. Moskowitz, Auayporn Nadamanee, Tamas Masszi, Edward Agura, Jerzy Holowiecki, Muneer H. Abidi, Andy I Chen, Patrick J. Stiff, Alessandro M. Gianni, Angelo M. Carella, Dzhelil Osmanov, Veronika Bachanova, John Sweetenham, Anna Sureda, Dirk Huebner, Emily K. Larsen, Naomi N.H. Hunder, Jan Walewski
Journal: Blood (2014)
Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.
Authors: Pilar Palomo Moraleda, Todd A. Alonzo, Robert B. Gerbing, Susana C. Raimondi, Betsy A. Hirsch, Yaddanapudi Ravindranath, Beverly Lange, William G. Woods, Alan S. Gamis, Soheil Meshinchi
Journal: Blood (2012)
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial
Authors: Andreas Hüttmann, Stefan P Müller, Jan Rekowski, Bernd Hertenstein, Christiane Franzius, Anke Franzke, Frank M Bengel, Frank Kroschinsky, Jörg Kotzerke, Paul La Rosée, Martin Freesmeyer, Heinz-Gert Hoeffkes, Andreas Hertel, Dirk Behringer, Rolf Mesters, Matthias Weckesser, Stefan Mahlmann, Uwe Haberkorn, Uwe Martens, Gabriele Prange-Krex, Agnieszka Korfel, Winfried Brenner, Aristoteles Giagounidis, Regina Moeller, Volker Runde, Matthias Sandmann, Hubertus Hautzel, Stefan Wilop, Thomas Krohn, Heinz Dürk, Dirk Strumberg, Michael Heike, Claudia Ose, Marcus Brinkmann, Guido Trenn, Otto Kloke, Christiane Kreisel-Büstgens, Tu-Anh Dang, Gerhard Heil, Karl-Heinz Jöckel, Dieter Hoelzer, Wolfram Klapper, Ulrich Duehrsen
Journal: Blood (2016)
High-Dose Calcitriol Modulates the Expression and Activity of Tissue Factor and Thrombomodulin in Tumor Cells.
Authors: Enriqueta Coll-Sangrona, Ali Amirkhosravi, Alshad S. Lalani, Liza Robles, Hina Desai, Mildred Amaya, John L. Francis
Journal: Blood (2007)
Analysis of VDT-PACE Utilization in Multiple Myeloma Patients Treated at MSKCC for Relapsed Disease or Cytoreduction and Stem Cell Mobilization after Initial Induction Therapy
Authors: Kristen Beyer, Samuel Rosner, Kaitlin M Woo, Sean M. Devlin, Heather Landau, Hani Hassoun, Nikoletta Lendvai, David J Chung, Nelly G. Adel, Marcin Puto, Ola Landgren, Sergio Giralt, Alexander M. Lesokhin
Journal: Blood (2014)
In Vitro and In Vivo Inhibition of the T315I Mutant BCR/ABL Kinase.
Authors: Hong Zhu, Ehab Hanna, Dan Lohse, Silva Stoughton, Betty Tam, Kathy Barrett, Glenn Noronha, Elena Dneprovskaia, Jon Cao, Chun Chow, Linda Hwang, Chiching Mak, Andy McPherson, Moorthy Palanki, Ved P. Pathak, Joe Renick, Richard Soll, Binqi Zeng, John Hood
Journal: Blood (2006)
Effect of YC-1, a HIF Inhibitor,On Apoptosis of Leukemia Cell.
Authors: Bao-An Chen, Fei Wang, Jian Cheng, Jia-Hua Ding, Wen-Lin Xu, Xue-Mei Wang, Chong Gao, Jun Wang, Gang Zhao, Wen Bao, Hui-Hui Song, Feng Gao, Wei Zhang, Guo-Hua Xia, Xiao-Ping Pei, Wei-Wei Wu, Ning-Na Chen
Journal: Blood (2009)
Whole-Genome Sequencing of a Monozygotic Twin Pair Reveals Functional Cooperative Mutations of SETD2 in Acute Leukemia
Authors: Xiaofan Zhu, Fuhong He, Huimin Zeng, Shaoping Ling, Xiaomei Yan, Yaqin Wang, Aili Chen, Wei Wei, Yue Zhang, Hui Cheng, Jun Wu, Xia Li, Lingtong Hao, Lihua Cao, Lili Dong, Wei Zou, Xuejing Yang, Xin Lu, Si Zheng, Jin Yan, Jing Zhou, Lixia Zhang, Shuangli Mi, Xiaojuan Wang, Li Zhang, Yao Zou, Yumei Chen, Zhe Geng, Jianfeng Zhou, Jianmin Wang, Xin Liu, Jianxiang Wang, Gang Huang, Weiping Yuan, Tao Cheng, Qian-fei Wang
Journal: Blood (2012)